Our people

Find out more about the people at Expedeon below.


CEO, CSO – Dr. Heikki Lanckriet, PhD

Heikki Lanckriet (PhD) has broad expertise and commercial experience in the Life Science Tools and Reagents area. In 2003, whilst at Cambridge University, Heikki co-founded Expedeon. He has since worked within the roles of COO, CSO and is currently CEO at Expedeon.

Heikki has a passion for science and innovation as well as strong commercial pragmatism. He holds a Bachelor’s and Master’s degree in Biochemical Engineering from the University of Ghent, Belgium and a PhD in Biochemical Engineering from the University of Cambridge, UK.

He has published papers in high impact peer-reviewed international scientific journals and is named inventor on a multitude of patents.

CTO, Dr Nick Gee, PhD 

Nick is a biochemist with over 20 years experience in the pharmaceutical and biotechnology industry with Merck & Co., Amersham International, Warner-Lambert and Upstate Biotechnology. He joined Warner-Lambert’s research facility in Cambridge in 1991 and was Head of Protein Biochemistry and Assay Development from 1994-1999. Nick was VP of Scientific Operations at Upstate’s new European base in Dundee from 1999-2002 after which he returned to Cambridge to set up Expedeon.

CFO, David Roth

David has over 20 years’ experience in and audit and accounting, with special focus in the healthcare sector. He is a chartered accountant having worked with KPMG, Deloitte and Arthur Andersen in the U.K., where he became a director and partner within the audit and advisory practice. Here he acted for a wide range of clients which included biotech as well as advising listed companies both in the UK and the US.

More recently he has worked as CFO in several multi location organizations, all of them in high growth healthcare businesses, leading financial and operational teams. This included reporting accountant on a $100m secondary NASDAQ listing and subsequent reporting roles, as well as analysis and financial support in several business acquisition and corporate transactions.

David is a German national living in the U.K.; he graduated from the University of Hertfordshire where he studied business.

CCO Miguel Viribay 

Miguel A Viribay (PhD) has developed a broad expertise in the Biotechnology, Life Science and Laboratory Instrumentation market arena.
In April 2015 he joined Expedeon as Vice President of Sales and Marketing and he was appointed CCO in July 2017.
Miguel joined the Application Specialist group at Perkin Elmer in 1998. Between 2006 and 2009 he assumed the position of Commercial Head for Iberia, and between 2009 and 2011 held the same position at a newly-created company Life Technologies. In 2011 Miguel assumed the leadership of the new business unit Life Science Group (LSG) at Agilent Technologies for Iberia and between April 2014 and April 2015 he held the position of Regional Manager at Fisher Scientific – part of Thermofisher Scientific.

Miguel holds a BS in Biochemistry and Molecular Biology specialty from the “Universidad Autónoma de Madrid” and a Doctorate in Science from the “Universidad Autónoma de Madrid”.